Igraine Plc - Unaudited Financial Statements to 31 December 2021 PR Newswire London, June 30 Igraine plc AQSE: KING ("Igraine" or "the company") Unaudited Financial
/PRNewswire/ Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™ (oral.
Trevi Therapeutics (TRVI) Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvio in the Treatment of Prurigo Nodularis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Entasis Therapeutics Holdings Inc (ETTX) Reports Efficacy and Safety Data from Phase 3 ATTACK Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.